You are here
IsoTherapeutics Group LLC
UEI: HPMNNTXWWKB3
# of Employees: 14
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
High Specific Activity Sn-117m by Post Irradiation Isotope Separation
Amount: $149,800.00The radioisotope tin-117m (117mSn) is a theranostic isotope that is suitable for both diagnostic and therapeutic applications. Its low energy gamma rays can be imaged using standard gamma cameras. F ...
SBIRPhase I2014Department of Energy -
A new radiopharmaceutical for the treatment of metastatic bone cancer
Amount: $1,490,797.00DESCRIPTION provided by applicant There are roughly new cases of metastatic cancer to the skeleton in the U S each year andquot Bone seekingandquot radiopharmaceuticals are used for bone ...
SBIRPhase II2013Department of Health and Human Services National Institutes of Health -
High Specific Activity Sm-153 by Post Irradiation Isotope Separation
Amount: $989,748.00Samarium-153 (153Sm) has ideal nuclear properties for a variety of therapeutic applications; however, it is only available in low specific activity (radioactivity/weight) form. While large quantitie ...
SBIRPhase II2012Department of Energy -
High Specific Activity Sm-153 by Post Irradiation Isotope Separation
Amount: $149,476.00When the stable samarium-152 (Sm-152) isotope is irradiated, radioactive samarium-153 (Sm-153) is produced through a neutron capture reaction in yields of only about 2%, and this radioactive, therapeu ...
SBIRPhase I2011Department of Energy -
A new radiopharmaceutical for the treatment of metastatic bone cancer
Amount: $143,582.00DESCRIPTION (provided by applicant): Bone-seeking radiopharmaceuticals are used extensively for bone pain palliation and have shown promise for treating bone metastases. They typically combine a rad ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health
